IP Library Granted Patent US 11,255,762
Granted Patent B1
US 11,255,762 · App. 16/990,366 · Granted Feb 22, 2022

Method and system for classifying sample data for robotically extracted samples

Inventors: Ozman Mohiuddin (Redmond, WA); Brian T. Sutch (Pasadena, CA); Mohammad Ali Mahmood (Garden Grove, CA)
Assignee: Specialty Diagnostic (SDI) Laboratories, Inc.
G01N1/31B01L3/508B01L3/5029C12Q1/6806B01L2200/025B01L2200/0678B01L2300/021B01L2300/04B01L2300/0809G01N2001/007G01N2001/028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,255,762
App. No.
16/990,366
Granted
Feb 22, 2022
Kind
B1
Abstract

A method of classifying sample data for robotically extracted samples is disclosed. A specimen is received from a human subject with a potential infection of a first disease agents or a plurality of disease agents. The specimen includes genetic material collected from a human subject using a collection device and stored in a collection carrier. The specimen includes a unique identifier on the collection carrier. The unique identifier contains human subject descriptive data. The method classifies the human subject descriptive data to identify a second disease agent. The method extracts a sequence of genetic material from the specimen using an automated robot. The method determines a test result for the first disease agent as a function of the sequence of genetic material. A system comprising a computer device configured to classify sample data for robotically extracted samples is also disclosed.

Claims (62)

1. A method of classifying sample data for robotically extracted samples, the method comprising:

receiving data related to a specimen from a human subject with a potential infection of a first disease agent, wherein the specimen comprises:

genetic material collected from the human subject using a collection device and stored in a collection carrier; and

a unique identifier on the collection carrier;

retrieving, by a computing device, human subject descriptive data from an optical scanning device as a function of the unique identifier;

classifying, at the computing device, the human subject descriptive data to identify a second disease agent, wherein classifying further comprises:

generating a classifier using a first machine-learning process as a function of human subject descriptive training data, wherein the human subject descriptive training data correlates human subject descriptive data with a second disease agent; and

generating the identity of the second disease agent as a function of the descriptive data and the classifier;

processing, by the computing device, a sequence of genetic material from the specimen prepared by an automated robot; and

obtaining, by the computing device, a test result determined by an analysis device for the first disease agent as a function of the sequence of genetic material.

2. The method of claim 1 , wherein the collection device comprises:

a swab; and

a transfer medium, wherein the swab is dipped in the transfer medium.

3. The method of claim 1 , wherein the collection device comprises blotting paper.

4. The method of claim 1 , wherein the first disease agent further comprises a coronavirus.

5. The method of claim 1 , further comprising determining a human subject contact profile,

wherein determining the human subject contact profile further comprises:

prompting a human subject for human subject intake data;

receiving human subject intake data as a function of the prompting;

generating a second machine learning process as a function of contact training data, wherein the contact training data correlates intake data elements with a human subject contact profile elements; and

determining the human subject contact profile as a function of the intake data and the second machine-learning process.

6. The method of claim 1 , wherein processing a sequence of genetic material from the specimen comprises:

aggregating, by the automated robot, a plurality of human subject specimens from a plurality of human subject specimen into a single extraction.

7. The method of claim 1 , wherein retrieving the human subject descriptive data further comprises:

performing, by the computing device, a textual conversation with the user, the textual conversation including transmitting to a user client device a plurality of potential user symptoms; and

receiving, at the computing device, a user selection of a potential user symptom from the plurality of user symptoms.

8. The method of claim 1 , wherein the test result further comprises a positive test result, and

further comprising:

establishing communication including an authorized human subject contact, by the computer device, as a function of the positive test result; and

initiating a conferencing event with the authorized contact.

9. The method of claim 1 , wherein the second disease agent is identical to the first disease agent.

10. The method of claim 1 further comprising:

determining, by the computing device, a presence of the first disease agent and the second disease agent in the specimen, wherein the first disease agent has a different identity from the second disease agent; and

generating, by the computing device a recommendation for the human subject, based on the determination.

11. A system of classifying sample data for robotically extracted samples, the system comprising a computing device configured to:

receive data related to a specimen from a human subject with a potential infection of a first disease agent, wherein the specimen comprises:

genetic material collected from the human subject using a collection device and stored in a collection carrier; and

a unique identifier on the collection carrier;

retrieve human subject descriptive data from an optical scanning device as a function of the unique identifier;

classify the human subject descriptive data to identify a second disease agent, wherein classifying further comprises, further comprising:

generate a classifier using a first machine-learning process as a function of human subject descriptive training data, wherein the human subject descriptive training data correlates human subject descriptive data with a second disease agent; and

generate the identity of the second disease agent as a function of the descriptive data and the classifier;

process a sequence of genetic material from the specimen prepared using an automated robot; and

obtain a test result determined using an analysis device for the first disease agent as a function of the sequence of genetic material.

12. The system of claim 11 , wherein the collection device comprises a swab; and

a transfer medium, wherein the swab is dipped in the transfer medium.

13. The system of claim 11 , wherein the collection device comprises blotting paper.

14. The system of claim 11 , wherein the first disease agent further comprises a coronavirus.

15. The system of claim 11 , wherein the computing device is further configured to:

prompt a human subject for intake data; and

generate a second machine learning process as a function of the intake data, wherein the second machine-learning process uses intake data as an input and outputs a human subject contact profile.

16. The system of claim 11 , wherein the computer device is further configured to process a sequence of genetic material from the specimen aggregated from a plurality of human specimens into a single extraction by the automated robot.

17. The system of claim 11 , wherein the computing device is further configured to:

perform a textual conversation with the user, the textual conversation including transmitting to the computing device, a plurality of potential user symptoms and receiving a human subject selection of a potential user symptom from the plurality of user symptoms; and

receive a user selection of a potential user symptom form the plurality of user symptoms.

18. The system of 11 , wherein the test result further comprises a positive test result, the computing device further configured to:

notify an authorized human subject contact of a positive test result; and

initiate a conferencing event with the authorized contact.

19. The system of claim 11 , wherein the second disease agent is identical to the first disease agent.

20. The system of claim 11 , wherein the computing device is further configured to:

determine a presence of the first disease agent and the second disease agent in the specimen, wherein the first disease agent has a different identity from the second disease agent; and

generate a recommendation for the human subject based on the determination.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Oct 9, 2024
From: SDI GLOBAL LLC (F/K/A SPECIALTY DIAGNOSTICS (SDI) GLOBAL LLC)
To: ADVANZINNOVATION LLC
Reel/Frame 068847/0805 →
NUNC PRO TUNC ASSIGNMENT Recorded Sep 6, 2024
From: SDI LABS, INC. (F/K/A SPECIALTY DIAGNOSTICS (SDI) LABORATORIES, INC.)
To: SDI GLOBAL LLC (F/K/A SPECIALTY DIAGNOSTICS (SDI) GLOBAL LLC)
Reel/Frame 068507/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2022
From: MOHIUDDIN, OZMAN
To: SPECIALTY DIAGNOSTIC (SDI) GLOBAL
Reel/Frame 061195/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2020
From: MOHIUDDIN, OZMAN; MAHMOOD, MOHAMMAD ALI; SUTCH, BRIAN T.
To: SPECIALTY DIAGNOSTIC (SDI) LABORATORIES, INC.
Reel/Frame 053563/0097 →